Friday, December 26, 2025 | 03:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 71 - Sohini Das

Booster dose: Dose gap, natural infection slow offtake among 60-plus

Experts are also questioning the nine-month gap between the second and the third doses

Booster dose: Dose gap, natural infection slow offtake among 60-plus
Updated On : 24 Feb 2022 | 6:04 AM IST

India confirms first Omicron-related death as Covid-19 cases jump

As cases continued to rise across the country, several state governments were forced to issue fresh guidelines on restrictions

India confirms first Omicron-related death as Covid-19 cases jump
Updated On : 06 Jan 2022 | 3:02 AM IST

Molnupiravir not in national clinical protocol due to safety concerns

ICMR chief says task force has debated twice on whether to include the drug in the protocol, but decided against it

Molnupiravir not in national clinical protocol due to safety concerns
Updated On : 06 Jan 2022 | 12:20 AM IST

Stricter Covid-19 curbs back in India as Omicron cases multiply

Weekend curfew in Delhi; Mumbai warns of lockdown if daily cases cross 20,000

Stricter Covid-19 curbs back in India as Omicron cases multiply
Updated On : 05 Jan 2022 | 1:03 AM IST

Price war rages as pharma firms despatch Covid-19 antiviral pill

Competitive pricing among firms keeps rates at Rs 1,400-2,490 for full treatment

Price war rages as pharma firms despatch Covid-19 antiviral pill
Updated On : 05 Jan 2022 | 6:10 AM IST

Bharat Biotech starts re-labelling old stock after shelf life extension

After receiving the order from the Central Drugs Standard Control Organisation (CDSCO), the company started lifting unused stock from hospitals to re-label the shelf life from 9 months to 12 months

Bharat Biotech starts re-labelling old stock after shelf life extension
Updated On : 04 Jan 2022 | 12:49 AM IST

Mixing Covaxin and Covishield induces four times more antibodies: Study

The Spike-protein neutralizing antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups

Mixing Covaxin and Covishield induces four times more antibodies: Study
Updated On : 04 Jan 2022 | 12:45 AM IST

Third Covid-19 wave is here; 75% cases in metros Omicron: NTAGI's N K Arora

New variant in 81% of samples genome tested: Delhi health minister

Third Covid-19 wave is here; 75% cases in metros Omicron: NTAGI's N K Arora
Updated On : 04 Jan 2022 | 12:10 AM IST

Covid-19 pandemic: Expect a slow but steady start to teen vaccination

Day 1 to see a few hundred shots administered at most sites

Covid-19 pandemic: Expect a slow but steady start to teen vaccination
Updated On : 03 Jan 2022 | 6:10 AM IST

Hospital sector could grow at 18% when Covid ends: Manipal Hospitals CEO

The Omicron situation is still evolving but the early signs are ominous, says Jose

Hospital sector could grow at 18% when Covid ends: Manipal Hospitals CEO
Updated On : 01 Jan 2022 | 6:10 AM IST

Indian drugmakers get close to nod for Merck's Covid antiviral Molnupiravir

The significance of the Molnupiravir approval is that it could offer an affordable oral drug to treat Covid-19, and may even be effective against the Omicron variant

Indian drugmakers get close to nod for Merck's Covid antiviral Molnupiravir
Updated On : 02 Dec 2021 | 11:37 PM IST

Action on Omicron: Step up testing to spot new variant, says govt

The health ministry also asked states to make sure testing of international passengers is done on the first and the eighth day scrupulously

Action on Omicron: Step up testing to spot new variant, says govt
Updated On : 01 Dec 2021 | 2:26 AM IST

Companies gear up for Omicron version of coronavirus vaccines

Zydus to keep a laboratory product ready based on the new variant

Companies gear up for Omicron version of coronavirus vaccines
Updated On : 01 Dec 2021 | 6:10 AM IST

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

Bharat Biotech's Covaxin set to go global after WHO gives it a booster
Updated On : 04 Nov 2021 | 12:03 AM IST

WHO grants much-awaited emergency use listing to Bharat Biotech's Covaxin

Move will ease international travel for those vaccinated with the jab

WHO grants much-awaited emergency use listing to Bharat Biotech's Covaxin
Updated On : 03 Nov 2021 | 7:23 PM IST

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals

Mixing multiple strains to get what is called a multi-variant vaccine may be a way to get better immunity, scientists feel

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals
Updated On : 31 Oct 2021 | 11:22 PM IST

Efforts upped for tracing AY.4.2 Covid strain, boosting vaccination

INSACOG expanded, ASHA workers doing man to man surveys, tracking and tracing on

Efforts upped for tracing AY.4.2 Covid strain, boosting vaccination
Updated On : 30 Oct 2021 | 12:56 AM IST

DRL plans to start paediatric trials of Sputnik Light vaccine soon

Booster shot with Sputnik trials may also begin

DRL plans to start paediatric trials of Sputnik Light vaccine soon
Updated On : 29 Oct 2021 | 11:11 PM IST

Covid cases slow down in festival season but watch out for Diwali: Experts

Vaccinations and more people having already got the disease may have lowered the count.

Covid cases slow down in festival season but watch out for Diwali: Experts
Updated On : 29 Oct 2021 | 1:09 AM IST

Power crisis brewing in China likely to hit Indian pharma companies

Delays in consignments, rising prices of key ingredients worry industry

Power crisis brewing in China likely to hit Indian pharma companies
Updated On : 28 Oct 2021 | 6:05 AM IST